These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 11374135
21. [The effect of cellulose diacetate dialysis membranes on lipids and lipoproteins in uremic patients]. Jakić M, Rupcić V, Stipanić S, Samardzija G, Bilandzija M, Zibar L, Mihaljević D, Milas J. Lijec Vjesn; 1997 Feb; 119(2):56-9. PubMed ID: 9297037 [Abstract] [Full Text] [Related]
22. Modification of serum and membrane lipid composition induced by diet in patients with chronic renal failure. Loschiavo C, Ferrari S, Aprili F, Grigolini L, Faccini G, Maschio G. Clin Nephrol; 1990 Dec; 34(6):267-71. PubMed ID: 2073770 [Abstract] [Full Text] [Related]
23. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients. Afzali B, Bakri RS, Bharma-Ariza P, Lumb PJ, Dalton N, Turner NC, Wierzbicki AS, Crook MA, Goldsmith DJ. J Nephrol; 2003 Dec; 16(4):540-5. PubMed ID: 14696756 [Abstract] [Full Text] [Related]
25. Effect of uremia and hemodialysis on soluble L-selectin and leukocyte surface CD11b and L-selectin. Dou L, Brunet P, Dignat-George F, Sampol J, Berland Y. Am J Kidney Dis; 1998 Jan; 31(1):67-73. PubMed ID: 9428454 [Abstract] [Full Text] [Related]
26. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Svensson M, Schmidt EB, Jørgensen KA, Christensen JH. Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564 [Abstract] [Full Text] [Related]
27. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure]. Starzyk J, Bartelik S, Sarnecka S. Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940 [Abstract] [Full Text] [Related]
28. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study. Diop ME, Viron B, Bailleul S, Lefevre G, Fessi H, Maury J, Etienne J, Couderc R. Clin Nephrol; 2000 Sep; 54(3):210-7. PubMed ID: 11020019 [Abstract] [Full Text] [Related]
29. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study. Traut M, Haufe CC, Eismann U, Deppisch RM, Stein G, Wolf G. Blood Purif; 2007 Sep; 25(5-6):432-40. PubMed ID: 17957097 [Abstract] [Full Text] [Related]
30. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments. Lucchi L, Bergamini S, Iannone A, Perrone S, Stipo L, Olmeda F, Caruso F, Tomasi A, Albertazzi A. Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086 [Abstract] [Full Text] [Related]
31. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis. Lucchi L, Iannone A, Bergamini S, Stipo L, Perrone S, Uggeri S, Gatti V, Ferrari F, Tomasi A, Albertazzi A. Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346 [Abstract] [Full Text] [Related]
33. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia. Koter M, Broncel M, Chojnowska-Jezierska J, Klikczynska K, Franiak I. Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426 [Abstract] [Full Text] [Related]
34. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes. Thalhammer F, Rosenkranz AR, Burgmann H, Graninger W, Hollenstein U, Schenk P, Thalhammer-Scherrer R, Traindl O, Hörl WH, Breyer S. Wien Klin Wochenschr; 1997 May 23; 109(10):362-5. PubMed ID: 9200809 [Abstract] [Full Text] [Related]
35. [Phospholipid composition of erythrocytes in patients with chronic kidney failure]. Akalaev RN, Abidov AA. Vopr Med Khim; 1993 May 23; 39(5):43-5. PubMed ID: 8279143 [Abstract] [Full Text] [Related]
36. [Changes in the lipid content of erythrocytes in patients with chronic renal failure]. Witkowska J, Bober J, Chlubek D. Ann Acad Med Stetin; 2007 May 23; 53(2):46-51. PubMed ID: 18557376 [Abstract] [Full Text] [Related]
37. The effect of low dose omega-3 on plasma lipids in hemodialysis patients. Taziki O, Lessan-Pezeshki M, Akha O, Vasheghani F. Saudi J Kidney Dis Transpl; 2007 Nov 23; 18(4):571-6. PubMed ID: 17951945 [Abstract] [Full Text] [Related]
38. [Disordered lipid metabolism and the morphofunctional instability of the erythrocyte membranes in patients with terminal kidney failure]. Grinshteĭn IuI, Tereshchenko VP, Tereshchenko IuA, Romanova VIa. Ter Arkh; 1990 Nov 23; 62(6):84-8. PubMed ID: 2218935 [Abstract] [Full Text] [Related]
39. Plasma lipid patterns in chronic renal failure. Lamberth EL, Oates JA. Trans Am Soc Artif Intern Organs; 1975 Nov 23; 21():473-8. PubMed ID: 1146020 [Abstract] [Full Text] [Related]
40. [Thermal energy balance during hemodialysis: the role of the filter membrane]. Panzetta G, Bianco F, Galli G, Ianche M, Savoldi S, Vianello S, Vidi E, Cicinato P. G Ital Nefrol; 2002 Nov 23; 19(4):425-31. PubMed ID: 12369045 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]